It's pretty incredible that JNJ missed revenue so badly, and that their pharmaceutical sales were down 19% - that's nothing short of staggering.
Whenever medical, health insurance, pharma, etc. performance lags, that's a huge red flag on the true health (or lack thereof) of the economy...